Recombinant Human Albumin "Recombumin"
Supporting the development of advanced therapies at every stage, from research and development to application in humans.
Features and Benefits ■ Hydrophobic, forms a monolayer on the water surface, reducing surface adsorption ■ Prevents aggregation and minimizes instability by dispersing uniformly in solution ■ Scavenges free radicals and protects against oxidative stress ■ Functions as a pH buffer and nutrient source, supporting an optimal microenvironment for sustained cell survival ■ Supports cell viability during and after freeze preservation ■ A completely non-human and non-animal derived product, reducing logistical challenges
basic information
The Recombumin product portfolio consists of commercially available, high-quality recombinant human albumin derived from both animal and human sources. Recombumin serves as a multifunctional additive, excipient, and raw material, and its stabilization properties have been validated through years of use in multiple marketed life science products.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
Detailed information
Related Videos
catalog（2）
Download All Catalogs
News about this product（3）
-
[End] Speaker at the Cell Culture Medium Symposium hosted by Shonan I-Park.
This event has concluded. We will be exhibiting and presenting at the Cell Culture Medium Symposium at Shonan, held at Shonan Ai Park on September 13, 2024 (Friday). At our booth, we will introduce Sartorius's wide range of media, raw materials, and services that meet the needs of cell culture. *You can view the program in the "Related Materials." [Event Overview] Date and Time: September 13, 2024 (Friday) 10:00 AM - 5:45 PM Location: Shonan Ai Park or online *Pre-registration required [Our Seminar] Title: Recombumin | Enabling safe and robust manufacturing across various modalities with recombinant human albumin Speaker: Shiori Akiyama (Sales Development Specialist - Cell Lines, Media, Various Tests) Seminar Time: 3:40 PM - 4:10 PM Overview: This seminar will focus on Recombumin, a recombinant human albumin that improves cell viability after cryopreservation and has an effect on suppressing the aggregation of cells and vectors.
-
[Sending recorded video] Recombumin | Recombinant human albumin enabling safe and robust manufacturing across various modalities.
Registration for this webinar has closed. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. In biopharmaceutical manufacturing, productivity, consistency, and safety of processes are emphasized, but it is said that ensuring stability in cell gene therapy is particularly challenging. Recombumin, due to its diverse physicochemical properties, improves cell survival rates after freeze preservation and suppresses aggregation of cells and vectors, thereby enhancing process productivity. Its strengths include very small inter-batch variability, high safety due to the absence of animal-derived components, and a regulatory compliance system in place in Japan. In this webinar, we will welcome Mr. Kazushige Sugama, a technical advisor from Albumedix, as a guest speaker to introduce examples of pharmaceutical manufacturing utilizing Recombumin's properties, particularly in gene cell therapy. 【Seminar Overview】 ▪ Date: March 7 (Thursday) from 3:00 PM (approximately 45 minutes) ▪ Format: Webinar recorded broadcast [Japanese, Free] *We sincerely apologize, but participation from companies in the same industry and email addresses other than those of your organization is not permitted. Thank you for your understanding.
-
Domestic Webinar: "Cultivation Products for Regenerative and Cell Therapy"
Expectations for regenerative medicine using stem cells such as mesenchymal stem cells (MSC) and induced pluripotent stem cells (iPSC) are rising, but for industrialization, there is a need for technology to produce high-quality cells in large quantities and in a stable manner. In this seminar, we will introduce xenofree stem cell culture media that do not contain components derived from animals other than humans, as well as examples of 3D culture using our microcarriers, bioreactors, and experimental design software. We will also present HEK media used for immune cell culture media and lentivirus production as products for cell therapy, such as CAR-T. 【Seminar Overview】 ▪ Date: October 12 (Thursday) from 3:00 PM (approximately 30 minutes) ▪ Format: Webinar recorded broadcast [Japanese, Free] If you are unable to attend on the day, please register first. Later, we will send you a link to download the recorded video and related product materials. *We apologize, but participation from other companies in the same industry, as well as email addresses not associated with your organization, is not permitted. Thank you for your understanding.
